News AZ's Alexion inks wide-ranging AI agreement with Verge AstraZeneca has made a sizeable play in applying artificial intelligence to drug discovery in its rare disease unit Alexion, partnering with Verge Genomics in a deal that
News Verge Genomics takes AI-sourced drug for ALS into clinic Verge Genomics has joined a select group of biotechs who have taken a drug discovered and developed using artificial intelligence into human testing.
R&D Ben Sidders on integrating causality in AI for R&D success Ben Sidders, chief scientific officer at Biorelate, discusses leveraging advanced data science methods to transform the focus and impact of R&D.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face